Á lódáil...
Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives
Dysregulation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin signaling is common in both indolent and aggressive forms of malignant lymphoma, for which several targeted therapies have been developed. Copanlisib is a highly selective and potent intravenous pan-...
Na minha lista:
| Foilsithe in: | Target Oncol |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer International Publishing
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941125/ https://ncbi.nlm.nih.gov/pubmed/33687623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-021-00802-9 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|